UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

MACC1-Dependent Antitumor Effect of Curcumin in Colorectal Cancer

Nutrients, 2022-11, Vol.14 (22), p.4792

2022

Volltextzugriff (PDF)

Learning from external stakeholders: Evidence from two railway projects in Germany

Project leadership and society, 2021-12, Vol.2, p.100028, Article 100028

2021

Volltextzugriff (PDF)

Induction of circulating ABCB1 transcripts under platinum-based chemotherapy indicates poor prognosis and a bone micrometastatic phenotype in ovarian cancer patients

Molecular cancer, 2024-08, Vol.23 (1), p.174-7

2024

Volltextzugriff (PDF)

Cantharidin and Its Analogue Norcantharidin Inhibit Metastasis-Inducing Genes S100A4 and MACC1

International journal of molecular sciences, 2023-01, Vol.24 (2), p.1179

2023

Volltextzugriff (PDF)

Clinical relevance of circulating MACC1 and S100A4 transcripts for ovarian cancer

Molecular oncology, 2019-05, Vol.13 (5), p.1268-1279

2019

Volltextzugriff (PDF)

Circulating MACC1 transcripts in colorectal cancer patient plasma predict metastasis and prognosis

PloS one, 2012-11, Vol.7 (11), p.e49249-e49249

2012

Volltextzugriff (PDF)

Integrative Marker Analysis Allows Risk Assessment for Metastasis in Stage II Colon Cancer

Annals of surgery, 2012-11, Vol.256 (5), p.763-771

2012

Volltextzugriff (PDF)

Circulating metastasis associated in colon cancer 1 transcripts in gastric cancer patient plasma as diagnostic and prognostic biomarker

World journal of gastroenterology : WJG, 2015-01, Vol.21 (1), p.333-341

2015

Volltextzugriff (PDF)

GIPC1 regulates MACC1-driven metastasis

Frontiers in oncology, 2023, Vol.13, p.1280977-1280977

2023

Volltextzugriff (PDF)

Intervening in β-Catenin Signaling by Sulindac Inhibits S100A4-Dependent Colon Cancer Metastasis

Neoplasia (New York, N.Y.), 2011-02, Vol.13 (2), p.131-IN8

2011

Volltextzugriff (PDF)

Nongenotoxic activation of the p53 pathway as a therapeutic strategy for multiple myeloma

Blood, 2005-11, Vol.106 (10), p.3609-3617

2005

Volltextzugriff (PDF)

Combined disruption of both the MEK/ERK and the IL-6R/STAT3 pathways is required to induce apoptosis of multiple myeloma cells in the presence of bone marrow stromal cells

Blood, 2004-12, Vol.104 (12), p.3712-3721

2004

Volltextzugriff (PDF)

Diagnostic and Prognostic Value of Metastasis Inducer S100A4 Transcripts in Plasma of Colon, Rectal, and Gastric Cancer Patients

The Journal of molecular diagnostics : JMD, 2011-03, Vol.13 (2), p.189-198

2011

Volltextzugriff (PDF)

Study on β‑Casein Depleted Casein Micelles: Micellar Stability, Enzymatic Cross-Linking, and Suitability as Nanocarriers

Journal of agricultural and food chemistry, 2020-11, Vol.68 (47), p.13940-13949

2020

Volltextzugriff (PDF)

In the presence of bone marrow stromal cells human multiple myeloma cells become independent of the IL-6/gp130/STAT3 pathway

Blood, 2002-11, Vol.100 (9), p.3311-3318

2002

Volltextzugriff (PDF)

Obesity, colorectal cancer and MACC1 expression: A possible novel molecular association

International journal of oncology, 2022-02, Vol.60 (2), p.1, Article 17

2022

Volltextzugriff (PDF)

RAGE mediates S100A4-induced cell motility via MAPK/ERK and hypoxia signaling and is a prognostic biomarker for human colorectal cancer metastasis

Oncotarget, 2014-05, Vol.5 (10), p.3220-3233

2014

Volltextzugriff (PDF)

Metastasis‐associated in colon cancer 1 is an independent prognostic biomarker for survival in klatskin tumor patients

Hepatology (Baltimore, Md.), 2015-09, Vol.62 (3), p.841-850

2015

Volltextzugriff (PDF)

Heterogeneity analysis of Metastasis Associated in Colon Cancer 1 (MACC1) for survival prognosis of colorectal cancer patients: a retrospective cohort study

BMC cancer, 2015-03, Vol.15 (1), p.160-160, Article 160

2015

Volltextzugriff (PDF)

Metastasis Associated in Colorectal Cancer 1 (MACC1) mRNA Expression Is Enhanced in Sporadic Vestibular Schwannoma and Correlates to Deafness

Cancers, 2023-08, Vol.15 (16), p.4089

2023

Volltextzugriff (PDF)

Niclosamide a new chemotherapy agent? Pharmacokinetics of the potential anticancer drug in a patient cohort of the NIKOLO trial

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.e14536-e14536

2018

Volltextzugriff (PDF)

Combination of Wnt/β-Catenin Targets S100A4 and DKK1 Improves Prognosis of Human Colorectal Cancer

Cancers, 2021-12, Vol.14 (1), p.37

2021

Volltextzugriff (PDF)

Elevated MACC1 Expression in Colorectal Cancer Is Driven by Chromosomal Instability and Is Associated with Molecular Subtype and Worse Patient Survival

Cancers, 2022-03, Vol.14 (7), p.1749

2022

Volltextzugriff (PDF)

High MACC1 expression in combination with mutated KRAS G13 indicates poor survival of colorectal cancer patients

Molecular cancer, 2015-02, Vol.14 (1), p.38-38, Article 38

2015

Volltextzugriff (PDF)

Abstract 5583: Plasma levels of circulating MACC1 transcripts co-segregate with other prognostic markers and treatment response in glioblastoma patients

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.5583-5583

2018

Volltextzugriff (PDF)

1 – 25 von 86

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(67)
Mit Volltextzugriff
(81)

Publikationsform

Sprache

Englisch
(74)
Deutsch
(12)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

MACC1-Dependent Antitumor Effect of Curcumin in Colorectal Cancer

Learning from external stakeholders: Evidence from two railway projects in Germany

Induction of circulating ABCB1 transcripts under platinum-based chemotherapy indicates poor prognosis and a bone micrometastatic phenotype in ovarian cancer patients

Cantharidin and Its Analogue Norcantharidin Inhibit Metastasis-Inducing Genes S100A4 and MACC1

Clinical relevance of circulating MACC1 and S100A4 transcripts for ovarian cancer

Circulating MACC1 transcripts in colorectal cancer patient plasma predict metastasis and prognosis

Integrative Marker Analysis Allows Risk Assessment for Metastasis in Stage II Colon Cancer

Circulating metastasis associated in colon cancer 1 transcripts in gastric cancer patient plasma as diagnostic and prognostic biomarker

GIPC1 regulates MACC1-driven metastasis

Intervening in β-Catenin Signaling by Sulindac Inhibits S100A4-Dependent Colon Cancer Metastasis

Nongenotoxic activation of the p53 pathway as a therapeutic strategy for multiple myeloma

Combined disruption of both the MEK/ERK and the IL-6R/STAT3 pathways is required to induce apoptosis of multiple myeloma cells in the presence of bone marrow stromal cells

Diagnostic and Prognostic Value of Metastasis Inducer S100A4 Transcripts in Plasma of Colon, Rectal, and Gastric Cancer Patients

Study on β‑Casein Depleted Casein Micelles: Micellar Stability, Enzymatic Cross-Linking, and Suitability as Nanocarriers

In the presence of bone marrow stromal cells human multiple myeloma cells become independent of the IL-6/gp130/STAT3 pathway

Obesity, colorectal cancer and MACC1 expression: A possible novel molecular association

RAGE mediates S100A4-induced cell motility via MAPK/ERK and hypoxia signaling and is a prognostic biomarker for human colorectal cancer metastasis

Metastasis‐associated in colon cancer 1 is an independent prognostic biomarker for survival in klatskin tumor patients

Heterogeneity analysis of Metastasis Associated in Colon Cancer 1 (MACC1) for survival prognosis of colorectal cancer patients: a retrospective cohort study

Metastasis Associated in Colorectal Cancer 1 (MACC1) mRNA Expression Is Enhanced in Sporadic Vestibular Schwannoma and Correlates to Deafness

Niclosamide a new chemotherapy agent? Pharmacokinetics of the potential anticancer drug in a patient cohort of the NIKOLO trial

Combination of Wnt/β-Catenin Targets S100A4 and DKK1 Improves Prognosis of Human Colorectal Cancer

Elevated MACC1 Expression in Colorectal Cancer Is Driven by Chromosomal Instability and Is Associated with Molecular Subtype and Worse Patient Survival

High MACC1 expression in combination with mutated KRAS G13 indicates poor survival of colorectal cancer patients

Abstract 5583: Plasma levels of circulating MACC1 transcripts co-segregate with other prognostic markers and treatment response in glioblastoma patients

Suchergebnisse filtern